Investing.com - Elanco Animal Health (NYSE: ELAN) reported second quarter EPS of $0.18, $0.13 better than the analyst estimate of $0.05. Revenue for the quarter came in at $1.06B versus the consensus estimate of $1.04B.
Guidance
Elanco Animal Health sees FY 2023 EPS of $0.80-$0.89 versus the analyst consensus of $0.80.
Elanco Animal Health sees FY 2023 revenue of $4.35B-$4.41B versus the analyst consensus of $4.35B.
Elanco Animal Health's stock price closed at $11.65. It is up 29.44% in the last 3 months and down -41.49% in the last 12 months.
Elanco Animal Health saw 0 positive EPS revisions and 9 negative EPS revisions in the last 90 days. See Elanco Animal Health's stock price’s past reactions to earnings here.
According to InvestingPro, Elanco Animal Health's Financial Health score is "good performance".
Check out Elanco Animal Health's recent earnings performance, and Elanco Animal Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar